Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease.

2021 
This retrospective case series study examines immune response of adults with hematologic malignant disease who were vaccinated with 1 of 3 FDA-authorized COVID-19 vaccines between February and April of 2021.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    6
    References
    5
    Citations
    NaN
    KQI
    []